Lotus Pharmaceuticals Inc logo

LTUS - Lotus Pharmaceuticals Inc Share Price

$0.074 0.0  23.3%

Last Trade - 3:28pm

Sector
Healthcare
Size
Small Cap
Market Cap £126.9m
Enterprise Value £130.7m
Revenue £50.9m
Position in Universe th / 6633
Bullish
Bearish
Unlock LTUS Revenue
Momentum
Relative Strength (%)
1m +229.9%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -50.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2005 2006 2007 2008 2009 2010 2011E 2012E CAGR / Avg
18.3 36.2 56.9 73.8 56.5 72.7 +31.7%
+124.5 +101.1 +28.9 +36.0 +8.0
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2011, LotusPharmaceuticals Inc revenues decreased 3% to $50.7M. Netincome applicable to common stockholders decreased 71% to$5.2M. Revenues reflect Wholesale & Third PartyManufacturing & Examination segment remaining flat at$15.3M. Net income also reflects Research and developmentexpenses increase from $22K to $1.9M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

LTUS Revenue Unlock LTUS Revenue

Net Income

LTUS Net Income Unlock LTUS Revenue

Normalised EPS

LTUS Normalised EPS Unlock LTUS Revenue

PE Ratio Range

LTUS PE Ratio Range Unlock LTUS Revenue

Dividend Yield Range

LTUS Dividend Yield Range Unlock LTUS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
LTUS EPS Forecasts Unlock LTUS Revenue
Profile Summary

Lotus Pharmaceuticals, Inc. (Lotus) develops, manufactures, and sells pharmaceuticals in the China. The Company produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. Its drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. It operates, controls and owns the pharmaceutical businesses in China of Beijing Liang Fang Pharmaceutical Co., Ltd. (Liang Fang) and Beijing En Zhe Jia Shi Pharmaceutical Co., Ltd. (En Zhe Jia), collectively Lotus East. Lotus East is engaged in the production, trade and retailing of pharmaceuticals, focusing on the development of medicines and investing in strategic growth to address various medical needs. Lotus East owns and operates 10 drug stores throughout Beijing, China that sell Western and traditional Chinese medications, and generate revenues from the leasing of retail space to third party vendors in its retail stores.

Directors
Last Annual December 31st, 2010
Last Interim September 30th, 2011
Incorporated January 28, 2004
Public Since May 15, 2012
No. of Shareholders: 58
No. of Employees: 233
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 2,944,515,543
Free Float (0.0%)
Eligible for
ISAs
SIPPs
LTUS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for LTUS
Upcoming Events for LTUS
Frequently Asked Questions for Lotus Pharmaceuticals Inc
What is the Lotus Pharmaceuticals Inc share price?

As of 3:28pm, shares in Lotus Pharmaceuticals Inc are trading at $0.074, giving the company a market capitalisation of £126.9m. This share price information is delayed by 15 minutes.

How has the Lotus Pharmaceuticals Inc share price performed this year?

Shares in Lotus Pharmaceuticals Inc are currently trading at $0.074 and the price has moved by 0.362k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Lotus Pharmaceuticals Inc price has moved by 0.268k% over the past year.

What are the analyst and broker recommendations for Lotus Pharmaceuticals Inc?

There are no analysts currently covering Lotus Pharmaceuticals Inc.

When will Lotus Pharmaceuticals Inc next release its financial results?

Lotus Pharmaceuticals Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2012-09-30
What is the Lotus Pharmaceuticals Inc dividend yield?

Lotus Pharmaceuticals Inc does not currently pay a dividend.

Does Lotus Pharmaceuticals Inc pay a dividend?

Lotus Pharmaceuticals Inc does not currently pay a dividend.

When does Lotus Pharmaceuticals Inc next pay dividends?

Lotus Pharmaceuticals Inc does not currently pay a dividend.

How do I buy Lotus Pharmaceuticals Inc shares?

To buy shares in Lotus Pharmaceuticals Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Lotus Pharmaceuticals Inc?

Shares in Lotus Pharmaceuticals Inc are currently trading at $0.074, giving the company a market capitalisation of £126.9m.

Where are Lotus Pharmaceuticals Inc shares listed? Where are Lotus Pharmaceuticals Inc shares listed?

Here are the trading details for Lotus Pharmaceuticals Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: LTUS
What kind of share is Lotus Pharmaceuticals Inc?

We were not able to load our ranking data for Lotus Pharmaceuticals Inc

Is there a Lotus Pharmaceuticals Inc share price forecast 2021?

We were not able to load any forecast data for Lotus Pharmaceuticals Inc.

How can I tell whether the Lotus Pharmaceuticals Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lotus Pharmaceuticals Inc. Over the past six months, the relative strength of its shares against the market has been 0.645k%. At the current price of $0.074, shares in Lotus Pharmaceuticals Inc are trading at 0.303k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Lotus Pharmaceuticals Inc PE Ratio?

The Lotus Pharmaceuticals Inc PE ratio based on its reported earnings over the past 12 months is 0.27. The shares are currently trading at $0.074.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Lotus Pharmaceuticals Inc?

Lotus Pharmaceuticals Inc's management team is headed by:

Zhongyi Liu - CEO
Yan Zeng - CFO
Xing Shen - VPR
Lu Jun - DRC
Fan Lijun - IND
Li Zhaohui - IND
Who are the major shareholders of Lotus Pharmaceuticals Inc?

Here are the top five shareholders of Lotus Pharmaceuticals Inc based on the size of their shareholding:

Tradition Asset Management LLC Investment Advisor
Percentage owned: % (n/a shares)
Similar to LTUS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.